The short answer
The survival number you found is a population average from people diagnosed years ago. What it measures, why the data lags, how stage changes it, and what it cannot say about you.
Five-year relative survival compares people with a cancer to the general population of the same age and sex, estimating survival from the cancer while excluding other causes of death.
Five years is a reporting convention, not a life expectancy or a limit.
The data lags badly: current SEER five-year survival statistics are based on people diagnosed between 2016 and 2022, so they reflect treatment as it was up to a decade ago.
Stage-specific figures differ enormously from the headline: female breast cancer is 91.9 percent overall but 100 percent localized and 33.8 percent distant, and lung cancer is 29.5 percent overall but 65.5 percent localized and 10.5 percent distant.
Watch: What a 5-year survival rate really means
54 sec · Captioned · What a 5-year survival rate measures, and why it can't predict an individual.
Educational only — this video explains general report language and is not medical advice. Only your care team can say what a result means for you.
Choose how you want to understand this
The full explanation.
What You Just Read, and What It Actually Was
You typed your cancer into a search box and a percentage came back. It is now lodged in your head as a personal forecast. Start here: that number is a population average. It describes people who were diagnosed years ago. It cannot tell you what will happen to you.
That is not a comforting spin. It is what the statistic is, technically. Understanding how it is built changes what it is entitled to say about you.
Five-Year Relative Survival, Unpacked
The headline figure is usually five-year relative survival. It compares people with a given cancer to people in the general population of the same age and sex. It estimates the percentage expected to survive the effects of that cancer, and it leaves out the risk of dying from other causes.
Three consequences follow immediately.
It is five years, not a life expectancy. Five years is a reporting convention, not a limit. People who are alive at five years are not at the end of anything. For many cancers, the risk of the cancer returning has fallen a lot by then.
It is an average across everyone. Every stage, every subtype, every age, and every level of fitness is pooled into one number. That includes people who were diagnosed very late, and people who could not have treatment at all.
It describes a group, not a person. As the National Cancer Institute puts it, statistics are based on large groups of people and cannot be used to predict exactly what will happen to you.
The Data Is Older Than It Looks
This is the part almost nobody notices. To publish a five-year survival figure, registries need people diagnosed at least five years ago and followed since. The SEER program's current five-year relative survival statistics are based on people diagnosed between 2016 and 2022.
So a number you read today reflects diagnosis, staging, and treatment as they existed up to a decade ago. Anyone diagnosed in 2016 was treated with 2016 medicine. That was before a great many immunotherapy and targeted-therapy approvals. It was before current radiation therapy techniques, and before several changes in surgical practice.
Survival figures also move. Modeled SEER trends for lung and bronchus cancer show five-year relative survival rising from roughly 20 percent for people diagnosed around 2012 to roughly 28 percent a few years later. The published statistic is a rear-view mirror.
Stage Changes Everything, and the Headline Hides It
Averaging across stages produces a number that may match almost nobody. Here are two real examples, both from SEER data on people diagnosed 2016 to 2022.
Female breast cancer: 91.9 percent overall — but 100 percent for localized disease, 87.5 percent for regional spread, and 33.8 percent when it has spread to distant sites.
Lung and bronchus cancer: 29.5 percent overall — but 65.5 percent for localized disease, 38.2 percent regional, and 10.5 percent distant. The frightening headline is largely produced by one fact. Just over half of lung cancers are found after they have spread.
If you have localized disease and you read the all-stages figure, you are reading a number shaped mostly by people in a different situation from yours.
What Else the Number Does Not Know
It does not know your subtype or your biomarkers, meaning the specific molecular features of your cancer. For many cancers those now drive treatment and outcome more than stage alone. It does not know your age, your other health conditions, or your treatment plan. It does not know whether you are eligible for a trial. Everyone is different, and responses to treatment vary greatly.
Making It Useful Instead of Terrifying
Bring the number to your oncologist rather than trying to reason with it alone. Ask what the figures are for your stage, your subtype, and your treatment plan specifically. Ask how current they are. Ask whether they predate any treatment you are being offered.
If searching has become compulsive, that is worth saying too. Distress can be measured and treated. You can request a psycho-oncology referral by name — that is mental health care built for people affected by cancer.
Sources
Words to know
Tap any term to see what it means.
Common questions
What does five-year relative survival actually measure?
It estimates the percentage of people expected to survive the effects of their cancer, compared with people of the same age and sex in the general population, and it excludes the risk of dying from other causes. It is a group average, not a prediction.
Does a five-year survival rate mean I have five years?
No. Five years is a reporting convention chosen because registries need that much follow-up to publish a figure. People alive at five years are not at the end of anything, and for many cancers the risk of recurrence has fallen substantially by that point.
How old is the data behind these numbers?
Older than it looks. To publish a five-year figure, registries need people diagnosed at least five years ago and followed since. The current SEER five-year relative survival statistics cover people diagnosed 2016 to 2022, so they reflect medicine as practiced up to a decade ago.
Why is the headline number so different from my stage?
Because it averages every stage, subtype, age, and level of fitness together. Female breast cancer is 91.9 percent across all stages but 100 percent for localized disease and 33.8 percent for distant. Lung cancer is 29.5 percent overall but 65.5 percent localized.
What should I do with the number now?
Bring it to your oncologist rather than reasoning with it alone. Ask for figures specific to your stage, subtype, and treatment plan, how current they are, and whether they predate treatments you are being offered.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer ExplainedSources last checked: 2026-08-16 what this meansLast updated: 2026-08-17Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- A Symptom Is Not a Diagnosis
- What Symptoms Should I Call My Oncology Team About Today?
- Cancer-Prevention Claims: Evidence, Uncertainty, or Myth?
- Cancer Recurrence vs. A New Primary Cancer
- Median Survival Is Not an Expiration Date
- Waiting for Molecular and Biomarker Test Results
- When a Second Pathology Review Changes the Diagnosis
- When Your Cancer Stage Changes After Surgery
Still have questions?
Educational answers, plain language
Free to print and share